NG
REGN icon

Norden Group’s Regeneron Pharmaceuticals REGN Stock Holding History

Norden Group’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.03M Buy
1,645
+23
+1% +$15.7K 0.08% 209
2026
Q1 		$1.25M Buy
1,622
+163
+11% +$125K 0.12% 159
2025
Q4 		$1.13M Buy
1,459
+353
+32% +$240K 0.11% 168
2025
Q3 		$622K Buy
1,106
+563
+104% +$318K 0.06% 291
2025
Q2 		$285K Sell
543
-38
-7% -$21.2K 0.03% 456
2025
Q1 		$368K Buy
581
+81
+16% +$55.7K 0.04% 378
2024
Q4 		$356K Sell
500
-159
-24% -$133K 0.04% 381
2024
Q3 		$693K Buy
659
+244
+59% +$272K 0.08% 265
2024
Q2 		$436K Buy
415
+27
+7% +$26.2K 0.09% 239
2024
Q1 		$373K Buy
388
+126
+48% +$120K 0.08% 289
2023
Q4 		$230K Buy
+262
New +$216K 0.04% 241

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Norden Group's REGN Position: Q2 2026 in Review

Norden Group increased its Regeneron Pharmaceuticals (REGN) stake by 1.4% in Q2 2026, buying an estimated $15.7K and bringing the position to 1,645 shares worth $1.03M. The position accounts for 0.08% of the portfolio, ranked #209.

Norden Group first reported a position in REGN in Q4 2023 and has held it in 11 quarters since. The position peaked at $1.25M in Q1 2026. 1,340 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Norden Group held 1,645 shares of Regeneron Pharmaceuticals worth $1.03M as of Q2 2026.
  • Norden Group bought 23 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $15.7K.
  • Regeneron Pharmaceuticals made up 0.08% of Norden Group's portfolio in Q2 2026, its #209 holding.
  • Norden Group first reported a position in Regeneron Pharmaceuticals in Q4 2023 and has held it in 11 quarters since.
  • Norden Group's Regeneron Pharmaceuticals position peaked at $1.25M in Q1 2026.
  • 1,340 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Norden Group's 13F filing for Q2 2026, filed 29 Jul 2026.